Alice Till Appointed as Interim AAPS Executive Director

Till brings extensive, impactful scientific and association management experience to the AAPS position, including tenure as an AAPS Board member and as AAPS President in 2014-2015.  She will serve as Interim Executive Director beginning on September 5, 2019, while the organization conducts a search for its next full-time Executive Director.

“The Board of Directors is very pleased that Dr. Till has volunteered to assist the association during this critical transition period, and we look forward to working with her over the coming months,” said Dale Eric Wurster, Ph.D., AAPS President. “Alice has a proven track record as an exemplary organizational leader. Her vision, talent for collaboration and partnerships, and focus on member value will ensure that AAPS continues to be a leader in providing outstanding service to our members and the global pharmaceutical science community.”

Till previously served as vice president of Science Policy & Technical Affairs at Pharmaceutical Research and Manufacturers of America (PhRMA) after successful engagements as President of the Generic Pharmaceutical Industry Association (GPIA), cofounder of the International Generic Pharmaceutical Alliance (IGPA), and in senior pharmaceutical research and development positions with Merck & Co.

“It’s a privilege to give back in this small way to an organization that has given so much to me for over 30 years” said Till.  “I look forward to working with members, the Board of Directors, and staff to ensure that AAPS continues to move forward during a smooth staff leadership transition.”